These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 1980697
1. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia. Klerman GL. J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697 [Abstract] [Full Text] [Related]
2. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment. Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302 [Abstract] [Full Text] [Related]
3. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL. Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480 [Abstract] [Full Text] [Related]
4. Efficacy of benzodiazepines in panic disorder and agoraphobia. Ballenger JC. J Psychiatr Res; 1990 May; 24 Suppl 2():15-25. PubMed ID: 1980694 [Abstract] [Full Text] [Related]
5. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam. Swinson RP, Pecknold JC, Kuch K. Prog Neuropsychopharmacol Biol Psychiatry; 1987 May; 11(2-3):105-13. PubMed ID: 3628823 [Abstract] [Full Text] [Related]
6. Alprazolam in the treatment of panic attack patients with and without major depression. Pyke RE, Kraus M. J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978 [Abstract] [Full Text] [Related]
7. Drug treatment of panic disorder: early response to treatment as a predictor of final outcome. Albus M, Lecrubier Y, Maier W, Buller R, Rosenberg R, Hippius H. Acta Psychiatr Scand; 1990 Nov; 82(5):359-65. PubMed ID: 2281806 [Abstract] [Full Text] [Related]
8. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC. J Affect Disord; 1989 Nov; 16(1):49-58. PubMed ID: 2521651 [Abstract] [Full Text] [Related]
9. Alprazolam in the treatment of panic disorders. Liebowitz MR, Fyer AJ, Gorman JM, Campeas R, Levin A, Davies SR, Goetz D, Klein DF. J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059 [Abstract] [Full Text] [Related]
10. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment. Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D. J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907 [Abstract] [Full Text] [Related]
11. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam. Charney DS, Woods SW. J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308 [Abstract] [Full Text] [Related]
12. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M. J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490 [Abstract] [Full Text] [Related]
13. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS. J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912 [Abstract] [Full Text] [Related]
14. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment. Rosenberg R, Bech P, Mellergård M, Ottosson JO. Acta Psychiatr Scand Suppl; 1991 Apr; 365():39-45. PubMed ID: 1862733 [Abstract] [Full Text] [Related]
15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD. Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644 [Abstract] [Full Text] [Related]
16. Alprazolam treatment for panic disorders. Alexander PE, Alexander DD. J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205 [Abstract] [Full Text] [Related]
17. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. Başoğlu M, Marks IM, Kiliç C, Swinson RP, Noshirvani H, Kuch K, O'Sullivan G. Br J Psychiatry; 1994 May; 164(5):647-52. PubMed ID: 7921715 [Abstract] [Full Text] [Related]
18. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K. J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078 [Abstract] [Full Text] [Related]
19. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone. Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR. J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889 [Abstract] [Full Text] [Related]
20. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder? Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O. Eur Arch Psychiatry Clin Neurosci; 1991 Dec; 241(3):151-8. PubMed ID: 1790160 [Abstract] [Full Text] [Related] Page: [Next] [New Search]